Affinity-based microarrays for proteomic analysis of cancer tissues

Proteomics - Clinical Applications

Volumn 7, Issue 1-2, 2013, Pages 8-15

  Hoheisel, Jörg D ^a   Alhamdani, Mohamed S S ^a   Schröder, Christoph ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Antibody; Expression profiling; Immunoassay; Isoform proteomics

Indexed keywords

ANTIBODY; EPITOPE; IMMUNOGLOBULIN G ANTIBODY; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

AFFINITY BASED MICROARRAY; ANTIBODY MICROARRAY; ANTIGEN BINDING; BINDING AFFINITY; CANCER TISSUE; CLINICAL PRACTICE; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LIMIT OF DETECTION; MASS SPECTROMETRY; MEDICAL TECHNOLOGY; METHODOLOGY; MICROARRAY ANALYSIS; MOLECULARLY TARGETED THERAPY; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN MICROARRAY; PROTEIN MODIFICATION; PROTEIN STRUCTURE; PROTEIN TARGETING; PROTEOMICS; REVIEW; SENSITIVITY AND SPECIFICITY; TISSUE SECTION;

HUMANS; INDIVIDUALIZED MEDICINE; NEOPLASMS; PROTEIN ARRAY ANALYSIS; PROTEOMICS;

EID: 84872692945     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201200114     Document Type: Review

References (54)

1. The International Cancer Genome Consortium, International network of cancer genome projects. Nature 2010, 464, 993-998.
2. Pandey, A., Mann, M., Proteomics to study genes and genomes. Nature 2000, 405, 837-846.
3. HUPO - The Human Proteome Organization, A gene-centric human proteome project. Mol. Cell Proteomics 2010, 9, 427-429.
4. Kolch, W., Pitt, A., Functional proteomics to dissect tyrosine kinase signalling pathways in cancer. Nat. Rev. Cancer 2010, 10, 618-629.
5. Banci, L., Bertini, I., Luchinat, C., Mori, M., NMR in structural proteomics and beyond. Prog. Nucl. Magn. Reson. Spectrosc. 2010, 56, 247-266.
6. Bodenmiller, B., Wanka, S., Kraft, C., Urban, J. et al., Phosphoproteomic analysis reveals interconnected system-wide responses to perturbations of kinases and phosphatases in yeast. Sci. Signal 2010, 3, rs4.
7. Tian, Y., Zhang, H., Glycoproteomics and clinical applications. Proteomics Clin. Appl. 2010, 4, 124-132.
8. Brennan, D. J., O'Connor, D. P., Rexhepaj, E., Ponten, F. et al., Antibody-based proteomics, fast-tracking molecular diagnostics in oncology. Nat. Rev. Cancer 2010, 10, 605-617.
9. Wingren, C., Ingvarsson, J., Dexlin, L., Szul, D. et al., Design of recombinant antibody microarrays for complex proteome analysis: choice of sample labeling-tag and solid support. Proteomics 2007, 7, 3055-3065.
10. Olle, E.W., Sreekumar, A., Warner, R. L., McClintock, S. D. et al., Development of an internally controlled antibody microarray. Mol. Cell. Proteomics 2005, 4, 1664-1672.
11. Schröder, C., Jacob, A., Tonack, S., Radon, T. et al., Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-specific antibodies. Mol. Cell Proteomics 2010, 9, 1271-1280.
12. Taussig, M. J., Stoevesandt, O., Borrebaeck, C., Bradbury, A. et al., ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome. Nature Meth. 2007, 4, 13-17.
13. Uhlen, M., Mapping the human proteome using antibodies. Mol. Cell. Proteomics 2007, 6, 1455-1456.
14. Hust, M., Meyer, T., Voedisch, B., Rülker, T. et al., A human scFv antibody generation pipeline for proteome research. J. Biotechnol. 2011, 152, 159-170.
15. Gold, L., Ayers, D., Bertino, J., Bock, C. et al., Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS One 2010, 5, e15004.
16. Steinhauer, C., Wingren, C., Malmborg Hager, A. C., Borrebaeck, C. A. K., Single framework recombinant antibody fragments designed for protein chip applications. Biotechniques 2002, 33, S38-S45.
17. Flajnik, M. F., Deschacht, N., Muyldermans, S., A case of convergence: why did a simple alternative to canonical antibodies arise in sharks and camels? PLoS Biol. 2011, 9, e1001120.
18. Binz, H. K., Amstutz, P., Kohl, A., Stumpp, M. T. et al., High-affinity binders selected from designed ankyrin repeat protein libraries. Nat. Biotechnol. 2004, 22, 575-582.
19. Alhamdani, M. S., Schröder, C., Hoheisel, J. D., Analysis conditions for proteomic profiling of mammalian tissue and cell extracts with antibody microarrays. Proteomics 2010, 10, 3203-3207.
20. Dexlin-Mellby, L., Sandström, A., Antberg, L., Gunnarsson, J. et al., Design of recombinant antibody microarrays for membrane protein profiling of cell lysates and tissue extracts. Proteomics 2011, 11, 1550-1554.
21. MAQC Consortium, The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat. Biotechnol. 2006, 24, 1151-1161.
22. Alhamdani, M. S., Schröder, C., Werner, J., Giese, N. et al., Single-step procedure for the isolation of proteins at near-native conditions from mammalian tissue for proteomic analysis on antibody microarrays. J. Prot. Res. 2010, 9, 963-971.
23. Kusnezow, W., Syagailo, Y. V., Rüffer, S., Baudenstiel, N. et al., Optimal design of microarray immunoassays to compensate for kinetic limitations-theory and experiment. Mol. Cell. Proteomics 2006, 5, 1681-1696.
24. Schallmeiner, E., Oksanen, E., Ericsson, O., Spångberg, L. et al., Sensitive protein detection via triple-binder proximity ligation assays. Nat. Methods 2006, 4, 135-137.
25. Landegren, U., Vänelid, J., Hammond, M., Nong, R. Y. et al., Opportunities for sensitive plasma proteome analysis. Anal. Chem. 2012, 84, 1824-1830.
26. Coombs, K. M., Quantitative proteomics of complex mixtures. Expert Rev. Proteomics 2011, 8, 659-677.
27. Borrebaeck, C. A., Wingren, C., Design of high-density antibody microarrays for disease proteomics: key technological issues. J. Proteomics 2009, 72, 928-935.
28. Schmidt, R., Jacak, J., Schirwitz, C., Stadler, V. et al., Single-molecule detection on a protein-array assay platform for the exposure of a tuberculosis antigen. J. Proteomics Res. 2011, 10, 1316-1322.
29. Hodgkinson, V. C., ElFadl, L., Agarwal, V., Garimella, V. et al., Proteomic identification of predictive biomarkers of resistance to neoadjuvant chemotherapy in luminal breast cancer: a possible role for 14-3-3 theta/tau and tBID? J. Proteomics 2012, 75, 1276-1283.
30. Hodgkinson, V. C., ElFadl, D., Drew, P. J., Lind, M. J. et al., Repeatedly identified differentially expressed proteins (RIDEPs) from antibody microarray proteomic analysis. J. Proteomics 2011, 74, 698-703.
31. Hudelist, G., Pacher-Zavisin, M., Singer, C. F., Holper, T. et al., Use of high-throughput protein array for profiling of differentially expressed proteins in normal and malignant breast tissue. Breast Cancer Res. Treat. 2004, 86, 283-291.
32. Knezevic, V., Leethanakul, C., Bichsel, V. E., Worth, J. M. et al., Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics 2001, 1, 1271-1278.
33. Zander, K. A., Saavedra, M. T., West, J., Scapa, V. et al., Protein microarray analysis of nasal polyps from aspirin-sensitive and aspirin-tolerant patients with chronic rhinosinusitis. Am. J. Rhinol. Allergy 2009, 23, 268-272.
34. Spisak, S., Galamb, B., Sipos, F., Galamb, O. et al., Applicability of antibody and mRNA expression microarrays for identifying diagnostic and progression markers of early and late stage colorectal cancer. Dis. Markers 2010, 28, 1-14.
35. Madoz-Gurpide, J., Canamero, M., Sanchez, L., Solano, J. et al., A proteomics analysis of cell signaling alterations in colorectal cancer. Mol. Cell. Proteomics 2007, 6, 2150-2164.
36. Kaukinen, A., Kuusniemi, A. M., Lautenschlager, I., Jalanko, H., Glomerular endothelium in kidneys with congenital nephrotic syndrome of the Finnish type (NPHS1). Nephrol. Dial. Transplant 2008, 23, 1224-1232.
37. Ellmark, P., Ingvarsson, J., Carlsson, A., Lundin, B. S. et al., Identification of protein expression signatures associated with Helicobacter pylori infection and gastric adenocarcinoma using recombinant antibody microarrays. Mol. Cell. Proteomics 2006, 5, 1638-1646.
38. Guo, T., Lee, S. S., Ng, W. H., Zhu, Y. et al., Global molecular dysfunctions in gastric cancer revealed by an integrated analysis of the phosphoproteome and transcriptome. Cell Mol. Life Sci. 2011, 68, 1983-2002.
39. Chowdhury, U. R., Madden, B. J., Charlesworth, M. C., Fautsch, M. P., Proteome analysis of human aqueous humor. Invest. Ophthalmol. Vis. Sci. 2010, 51, 4921-4931.
40. Shie, J. H., Liu, H. T., Kuo, H. C., Increased cell apoptosis of urothelium mediated by inflammation in interstitial cystitis/painful bladder syndrome. Urology 2012, 79, 484.e7-13.
41. Bartling, B., Hofmann, H. S., Boettger, T., Hansen, G. et al., Comparative application of antibody and gene array for expression profiling in human squamous cell lung carcinoma. Lung Cancer 2005, 49, 145-154.
42. Moschos, S. J., Smith, A. P., Mandic, M., Athanassiou, C. et al., SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomas. Oncogene 2007, 26, 4216-4225.
43. Jarvinen, K., Vuolteenaho, K., Nieminen, R., Moilanen, T. et al., Selective iNOS inhibitor 1400W enhances anti-catabolic IL-10 and reduces destructive MMP-10 in OA cartilage. Survey of the effects of 1400W on inflammatory mediators produced by OA cartilage as detected by protein antibody array. Clin. Exp. Rheumatol. 2008, 26, 275-282.
44. Takeuchi, H., Kimura, T., Okamoto, K., Aoyagi, E. et al., A mechanism for abnormal angiogenesis in human radiation proctitis: analysis of expression profile for angiogenic factors. J. Gastroenterol. 2012, 47, 56-64.
45. Kaufman, K. L., Belov, L., Huang, P., Mactier, S. et al., An extended antibody microarray for surface profiling metastatic melanoma. J. Immunol. Methods 2010, 358, 23-34.
46. Alhamdani, M. S. S., Youns, M., Buchholz, M., Gress, T. M. et al., Immunoassay-based proteome profiling of 24 pancreatic cancer cell lines. J. Proteomics 2012, 75, 3747-3759.
47. Bereczki, E., Gonda, S., Csont, T., Korpos, E. et al., Overexpression of biglycan in the heart of transgenic mice: an antibody microarray study. J. Proteome Res. 2007, 6, 854-861.
48. Ayuso, M. I., García-Bonilla, L., Martín, M. E., Salinas, M., Assessment of protein expression levels after transient global cerebral ischemia using an antibody microarray analysis. Neurochem. Res. 2010, 35, 1239-1247.
49. Wolff, C., Schott, C., Porschewski, P., Reischauer, B. et al., Successful protein extraction from over-fixed and long-term stored formalin-fixed tissues. PLoS One 2011, 6, e16353.
50. Wood, L. D., Parsons, D. W., Jones, S., Lin, J. et al., The genomic landscapes of human breast and colorectal cancers. Science 2007, 318, 1108-1113.
51. Stratton, M. R., Campbell, P. J., Futreal, P. A., The cancer genome. Nature 2009, 458, 719-724.
52. Wang, Q., Chaerkady, R., Wu, J., Hwang, H. J. et al., Mutant protein as cancer-specific biomarkers. Proc. Natl. Acad. Sci. USA 2011, 108, 2444-2449.
53. Bignell, G. R., Greenman, C. D., Davies, H., Butler, A. P. et al., Signatures of mutation and selection in the cancer genome. Nature 2010, 463, 893-898.
54. Bozic, I., Antal, T., Ohtsuki, H., Carter, H. et al., Accumulation of driver and passenger mutations during tumor progression. Proc. Natl. Acad. Sci. USA 2010, 107, 18545-18550.